|
|
Article: Immune Response Bears Brunt of Partner's Pullout.(Agouron Pharmaceuticals will no longer fund development of its experimental HIV vaccine, Remune)(Brief Article)
- Article from:
- San Diego Business Journal
- Article date:
- July 16, 2001
- Author:
CopyrightCOPYRIGHT 2001 CBJ, L.P. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Biotech: Stock Falls on News of Lost Funds for HIV Vaccine Development
CARLSBAD -- Immune Response Corp. barely announced the withdrawal of its development and marketing partner When it was hit with a class-action lawsuit.
On July 6, the Carlsbad company's shares fell $2.01 to $2.58 after the firm reported Pfizer Inc.'s San Diego-based Agouron Pharmaceuticals unit will no longer fund development of its experimental HIV vaccine, Remune.
On July 11, attorney Edward J. Carreiro of Hatboro, Pa., filed a lawsuit on behalf of shareholders against Immune Response.
Laura Hansen, a company spokeswoman, said company officials were in Argentina ...